Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436
Tissue Engineering and Regenerative Medicine · 2026-08 · 23 (6) · 901-915
DOI: 10.1007/s13770-026-00823-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, online erschienen am 27.06.2026. Verfasst von Jianbo Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China. Hauptthemen laut MEDLINE: MicroRNAs, Apoptosis, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Jinhua Science and Technology Research Program, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by β-cell dysfunction and insulin resistance with limited treatment options. The targeting of pancreatic β-cell apoptosis and dedifferentiation represents a promising approach for T2DM therapy. Recently, mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have demonstrated repair potential for metabolic diseases. However, the effects of MSC-EVs on β-cell apoptosis and dedifferentiation in T2DM remain largely unclear. METHODS: We established db/db mouse model and high glucose-stimulated MIN6 cell model to evaluate the therapeutic efficacy of MSC-EVs in vivo and in vitro. Transcriptome sequencing, proteomic analysis, and microRNA (miRNA) sequencing were applied to explore the molecular mechanism underlying MSC-EV-induced β-cell protection. RESULTS: MSC-EVs significantly mitigated hyperglycemia, improved glucose tolerance, and restored β-cell function by preventing β-cell loss and reducing dedifferentiated β-cell populations in db/db mice. Mechanistically, MSC-EV treatment reversed hyperglycemia-induced ecotropic virus integration site 1 (EVI1) upregulation in β cells, and EVI1 knockdown significantly suppressed β-cell apoptosis and dedifferentiation by promoting forkhead box protein O1 (FOXO1) expression. MiRNA sequencing revealed that miR-4436 enriched in MSC-EVs inhibited EVI1 expression by directly binding to EVI1 mRNA. MiR-4436 knockdown abolished the therapeutic effects of MSC-EVs in T2DM CONCLUSION: MSC-EVs inhibit pancreatic β-cell loss and dedifferentiation by miR-4436-mediated EVI1/FOXO1 regulation. Therefore, MSC-EV administration may represent a promising therapeutic strategy for T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China.
- Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 365 Renmin East Road, Jinhua, 321000, Zhejiang, China. zjdxsyt@163.com.
- Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 365 Renmin East Road, Jinhua, 321000, Zhejiang, China. jsdxsft@163.com.
Förderung
- National Natural Science Foundation of China
- Jinhua Science and Technology Research Program
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Xu, J., Sun, Y., & Sun, F. (2026). Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436. Tissue Engineering and Regenerative Medicine, 23(6), 901-915. https://doi.org/10.1007/s13770-026-00823-3
Vancouver
Xu J, Sun Y, Sun F. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436. Tissue Engineering and Regenerative Medicine. 2026;23(6):901-915. doi:10.1007/s13770-026-00823-3
BibTeX
@article{Xu2026,
author = {Xu, Jianbo and Sun, Yuntong and Sun, Fengtian},
title = {Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436},
journal = {Tissue Engineering and Regenerative Medicine},
year = {2026},
volume = {23},
number = {6},
pages = {901--915},
doi = {10.1007/s13770-026-00823-3}
}
EUVIMED